摘要
目的观察健脾通络方治疗股骨头坏死继发髋骨关节炎的临床疗效。方法将90例股骨头坏死继发髋骨关节炎患者随机分为治疗组45例(55髋)和对照组45例(57髋)。治疗组采用健脾通络方联合髋关节腔冲洗及玻璃酸钠注射液治疗,对照组采用髋关节腔冲洗及玻璃酸钠注射液治疗。采用视觉模拟评分法(VAS)、Harris评分及Mitchell髋关节积液量分级作为疗效评价指标。对术后2周、3个月和6个月进行临床疗效随访。结果85例患者完成随访,共脱落5例(治疗组2例,共4髋;对照组3例,共5髋),脱落率5.88%。两组患者治疗后各随访点的评价指标均优于治疗前(P<0.05)。治疗后的治疗组各随访点的评价指标优于对照组,两组差异有统计学意义(P<0.05)。结论对于股骨头坏死继发髋骨关节炎患者,对照组和治疗组均取得了较好的临床疗效,但治疗组在缓解患者的疼痛、改善髋关节功能、控制积液量方面更具有优势,有助于提高股骨头坏死的保髋有效率,值得临床进一步推广应用。
Objective To observe the clinical effect of Jianpi Tongluo Decoction(健脾通络方)on osteoarthritis hip secondary to femoral head necrosis.Methods 90 patients with hip osteoarthritis secondary to femoral head necrosis were randomly divided into treatment group(45 cases,55 hips)and control group(45 cases,57 hips).The treatment group was treated with Jianpi Tongluo Decoction combined with hip joint cavity irrigation and sodium hyaluronate injection,while the control group was treated with hip joint cavity irrigation and sodium hyaluronate injection.VAS pain score,Harris score and Mitchell hip joint effusion volume classification were used as evaluation indexes.The clinical effects were followed up for 2 weeks,3 months and 6 months after operation.Results 85 patients completed the follow-up,a total of 5 cases(treatment group 2 cases,a total of 4 hips;control group of 3 cases,a total of 5 hips),the drop off rate was 5.88%.The evaluation indexes at each follow-up point after treatment in two groups were better than those before treatment(P<0.05).After treatment,the evaluation index of each follow-up point in the treatment group was better than that in the control group,and the difference was statistically significant(P<0.05).Conclusion For patients with hip osteoarthritis secondary to the femoral head necrosis,the control group and the treatment group have achieved good clinical efficacy,but the treatment group has more advantages in relieving the pain of patients,improving the hip joint function and controlling the amount of effusion,which helps to improve the effective rate of hip preservation of femoral head necrosis,which is worthy of further clinical application.
作者
王均玉
高欢欢
宋梦歌
薛志鹏
何海军
李龑
刘道兵
谢斌
WANG Junyu;GAO Huanhuan;SONG Mengge;XUE Zhipeng;HE Haijun;LI Yan;LIU Daobing;XIE Bin(Wangjing Hospital of China Academy of Chinese Medical Sciences,Beijing 100102,China)
出处
《辽宁中医药大学学报》
CAS
2021年第3期52-56,共5页
Journal of Liaoning University of Traditional Chinese Medicine
基金
国家自然科学基金(81873322)。
关键词
健脾通络方
股骨头坏死
髋骨关节炎
临床研究
Jianpi Tongluo Decoction(健脾通络方)
femoral head necrosis
hip osteoarthritis
clinical research
